跳至主要内容
临床试验/NCT00604552
NCT00604552终止不适用

AneuRx Post Market Surveillance Registry

Medtronic Cardiovascular8 个研究点 分布在 1 个国家目标入组 349 人开始时间: 2003年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
349
试验地点
8
主要终点
Evaluate the Occurrence of Death, Aneurysm Rupture, and Surgical Conversion

研究概览

简要总结

The aorta is a large blood vessel that carries blood away from the heart to the organs in the rest of the body. An aneurysm is a weakening in the artery wall that will become a bulge in the aorta. If left untreated, this bulge may continue to grow larger and may rupture (break open) with fatal consequences. Abdominal aortic aneurysm (AAA) is a life-threatening lesion that has been treated in recent year via endovascular repair.

The purpose of this study is to monitor the long term performance of the AneuRx Stent Graft Systems.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients implanted with an AneuRx Stent Graft per Instructions for Use
  • Patients must provide written informed consent and agree to be accessible for follow-up at the study center.

排除标准

  • 未提供

结局指标

主要结局

Evaluate the Occurrence of Death, Aneurysm Rupture, and Surgical Conversion

时间窗: 5 year

Number of patients that had an occurrence of death, aneurysm rupture or surgical conversion

次要结局

  • Evaluate the Occurance of Endoleak, Stent Graft Migration, Aneurysm Enlargement, Device Integrity and Adverse Events(5 years)

研究者

发起方
Medtronic Cardiovascular
申办方类型
Industry
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验